Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.

Nguyen EV, Pereira BA, Lawrence MG, Ma X, Rebello RJ, Chan H, Niranjan B, Wu Y, Ellem S, Guan X, Wu J, Skhinas JN, Cox TR, Risbridger GP, Taylor RA, Lister NL, Daly RJ.

Mol Cell Proteomics. 2019 Jul;18(7):1410-1427. doi: 10.1074/mcp.RA119.001496. Epub 2019 May 6.

2.

Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS.

Nesheim N, Ellem S, Dansranjavin T, Hagenkötter C, Berg E, Schambeck R, Schuppe HC, Pilatz A, Risbridger G, Weidner W, Wagenlehner F, Schagdarsurengin U.

Oncotarget. 2018 Apr 13;9(28):19623-19639. doi: 10.18632/oncotarget.24714. eCollection 2018 Apr 13.

3.

Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects.

Kügler R, Mietens A, Seidensticker M, Tasch S, Wagenlehner FM, Kaschtanow A, Tjahjono Y, Tomczyk CU, Beyer D, Risbridger GP, Exintaris B, Ellem SJ, Middendorff R.

FASEB J. 2018 Mar;32(3):1130-1138. doi: 10.1096/fj.201700430R. Epub 2018 Jan 3.

PMID:
29089445
4.

Age Related Differences in Responsiveness to Sildenafil and Tamsulosin are due to Myogenic Smooth Muscle Tone in the Human Prostate.

Lee SN, Chakrabarty B, Wittmer B, Papargiris M, Ryan A, Frydenberg M, Lawrentschuk N, Middendorff R, Risbridger GP, Ellem SJ, Exintaris B.

Sci Rep. 2017 Aug 31;7(1):10150. doi: 10.1038/s41598-017-07861-x.

5.

Convergence of regenerative medicine and synthetic biology to develop standardized and validated models of human diseases with clinical relevance.

Hutmacher DW, Holzapfel BM, De-Juan-Pardo EM, Pereira BA, Ellem SJ, Loessner D, Risbridger GP.

Curr Opin Biotechnol. 2015 Dec;35:127-32. doi: 10.1016/j.copbio.2015.06.001. Epub 2015 Jun 26. Review.

PMID:
26121082
6.

A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.

Ellem SJ, Taylor RA, Furic L, Larsson O, Frydenberg M, Pook D, Pedersen J, Cawsey B, Trotta A, Need E, Buchanan G, Risbridger GP.

J Pathol. 2014 Sep;234(1):86-98. doi: 10.1002/path.4386. Epub 2014 Jul 9.

PMID:
25042571
7.

In vitro modeling of the prostate cancer microenvironment.

Ellem SJ, De-Juan-Pardo EM, Risbridger GP.

Adv Drug Deliv Rev. 2014 Dec 15;79-80:214-21. doi: 10.1016/j.addr.2014.04.008. Epub 2014 May 9. Review.

PMID:
24816064
8.

Aromatase transgenic upregulation modulates basal cardiac performance and the response to ischemic stress in male mice.

Bell JR, Bernasochi GB, Varma U, Boon WC, Ellem SJ, Risbridger GP, Delbridge LM.

Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1265-74. doi: 10.1152/ajpheart.00012.2014. Epub 2014 Mar 7.

9.

Prostatitis and andrological implications.

Wagenlehner F, Pilatz A, Linn T, Diemer T, Schuppe HC, Schagdarsurengin U, Hossain H, Meinhardt A, Ellem S, Risbridger G, Weidner W.

Minerva Urol Nefrol. 2013 Jun;65(2):117-23.

PMID:
23703099
10.

A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.

Biomaterials. 2013 Jul;34(20):4777-85. doi: 10.1016/j.biomaterials.2013.03.005. Epub 2013 Apr 2.

PMID:
23562048
11.

Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations.

Hussain S, Lawrence MG, Taylor RA, Lo CY; APC BioResource, Frydenberg M, Ellem SJ, Furic L, Risbridger GP.

PLoS One. 2012;7(7):e40732. doi: 10.1371/journal.pone.0040732. Epub 2012 Jul 10.

12.

Breaking through a roadblock in prostate cancer research: an update on human model systems.

Toivanen R, Taylor RA, Pook DW, Ellem SJ, Risbridger GP.

J Steroid Biochem Mol Biol. 2012 Sep;131(3-5):122-31. doi: 10.1016/j.jsbmb.2012.01.005. Epub 2012 Feb 8. Review.

PMID:
22342674
13.

Brief report: a bioassay to identify primary human prostate cancer repopulating cells.

Toivanen R, Berman DM, Wang H, Pedersen J, Frydenberg M, Meeker AK, Ellem SJ, Risbridger GP, Taylor RA.

Stem Cells. 2011 Aug;29(8):1310-4. doi: 10.1002/stem.668.

14.

Aromatase and regulating the estrogen:androgen ratio in the prostate gland.

Ellem SJ, Risbridger GP.

J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):246-51. doi: 10.1016/j.jsbmb.2009.10.015. Epub 2009 Nov 5. Review.

PMID:
19896534
15.

Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy.

Ellem SJ, Wang H, Poutanen M, Risbridger GP.

Am J Pathol. 2009 Sep;175(3):1187-99. doi: 10.2353/ajpath.2009.081107. Epub 2009 Aug 21.

16.

The dual, opposing roles of estrogen in the prostate.

Ellem SJ, Risbridger GP.

Ann N Y Acad Sci. 2009 Feb;1155:174-86. doi: 10.1111/j.1749-6632.2009.04360.x. Review.

PMID:
19250203
17.

Estrogen-regulated development and differentiation of the prostate.

McPherson SJ, Ellem SJ, Risbridger GP.

Differentiation. 2008 Jul;76(6):660-70. doi: 10.1111/j.1432-0436.2008.00291.x. Epub 2008 Jun 28. Review.

PMID:
18557760
18.

The role of Eralpha and ERbeta in the prostate: insights from genetic models and isoform-selective ligands.

McPherson SJ, Ellem SJ, Patchev V, Fritzemeier KH, Risbridger GP.

Ernst Schering Found Symp Proc. 2006;(1):131-47. Review.

PMID:
17824175
19.

Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling.

Risbridger GP, Ellem SJ, McPherson SJ.

J Mol Endocrinol. 2007 Sep;39(3):183-8. Review.

PMID:
17766643
20.

Treating prostate cancer: a rationale for targeting local oestrogens.

Ellem SJ, Risbridger GP.

Nat Rev Cancer. 2007 Aug;7(8):621-7. Epub 2007 Jul 5. Review.

PMID:
17611544
21.

Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.

McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP.

Endocrinology. 2007 Feb;148(2):566-74. Epub 2006 Oct 26.

PMID:
17068134
22.

Aromatase and prostate cancer.

Ellem SJ, Risbridger GP.

Minerva Endocrinol. 2006 Mar;31(1):1-12. Review.

PMID:
16498360
23.

Local aromatase expression in human prostate is altered in malignancy.

Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M, Risbridger GP.

J Clin Endocrinol Metab. 2004 May;89(5):2434-41.

PMID:
15126575
24.

Oestrogens and prostate cancer.

Risbridger GP, Bianco JJ, Ellem SJ, McPherson SJ.

Endocr Relat Cancer. 2003 Jun;10(2):187-91. Review.

PMID:
12790781

Supplemental Content

Support Center